Moneycontrol
HomeNewsBusinessBudgetEconomic Survey 2023: PM Gati Shakti and National Logistics Policy to support domestic manufacturing, export competitiveness
Trending Topics

Economic Survey 2023: PM Gati Shakti and National Logistics Policy to support domestic manufacturing, export competitiveness

Economic Survey 2023: A total of Rs 1,458 crore has been spent as capital expenditure for the development of the PM Gati Shakti digital platform.

January 31, 2023 / 17:25 IST
Story continues below Advertisement

The Economic Survey 2023 noted that the infrastructure expansion has come at a time of crisis when the capital expenditure by the private sector has been subdued. (Representative Image)

India's domestic manufacturing and export competitiveness will be driven by the likes of the Production-Linked Incentive (PLI) scheme, PM Gati Shakti and National Logistics Policy (NLP), the Economic Survey, tabled by Finance Minister Nirmala Sitharaman in Parliament on January 31, said.

"Further support to economic growth will come from the expansion of public digital platforms and path-breaking measures such as PM GatiShakti, the National Logistics Policy, and the Production-Linked Incentive schemes to boost manufacturing output," the survey said.

Story continues below Advertisement

Union Minister for Finance, Nirmala Sitharaman on January 31 tabled in Parliament the Economic Survey 2022-2023, which reviews how the economy performed in this fiscal year and the road ahead for the next year.

The survey added the government's aim to reduce logistics cost through the NLP and improve coordination between ministries will be key in boosting domestic manufacturing in the country.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show